LSBio
TLR3 Antibody (phospho-Tyr759)

Immunofluorescence of IgG, AID and TLR3 (Polyclonal Antibody to TLR3 (Phospho Tyr759)) expression in a healthy donor (A) and a hyper-IgM (HIGM) syndrome patient (B and C). A and B: Paraformaldehyde-fixed, frozen tonsillar mucosa tissue sections. C. Paraformaldehyde-fixed, mucosal B cells from the colon lamina propria of the HIGM patient. Arrowheads indicate cells co-expressing phospho TLR3, AID, and IgG.

TLR3 Antibody (phospho-Tyr759)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Frozen, Western Blot
Reactivity:Human
Format:Liquid
See all Human TLR3 antibodies →
$394.00each
Catalog Number: LS-C19344-20

For bulk orders or custom formulations:

Request a Quote

Overview

Description
TLR3 antibody LS-C19344 is an unconjugated rabbit polyclonal antibody to human TLR3 (pTyr759). Validated for IF, IHC and WB. Cited in 1 publication.
Application
IF, IHC, IHC-F, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CD283 | Toll-like receptor 3 | TLR3 | CD283 antigen | IIAE2
UniProt Number
O15455
SwissProt
O15455

Target

Target
Human TLR3
Antigen Species
Human
Epitope
A portion of amino acids 750-800, containing a phosphorylated tyrosine residue at position 759, of human TLR3 was used as the immunogen.
Gene Name
TLR3

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen
A portion of amino acids 750-800, containing a phosphorylated tyrosine residue at position 759, of human TLR3.

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.05% Sodium Azide, 0.05% BSA
Concentration
0.2 mg/mL
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation. Sharma NR, Majerciak V, Kruhlak MJ, Zheng ZM. PLoS pathogens. 2017;13:e1006677. PubMed: 29084250

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.